Matthew Margolis, DO
Ophthalmology · Jonesboro, ARNPI 1972569036
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 50.8% of the total. Reporting peaked in 2019 at $9,387 and has fallen 89.3% since, to $1,002 in 2025. Among ophthalmology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $55.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$9K
- AbbVie$2K
- Sight Sciences, Inc.$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Biotissue Holdings Inc.$1K
- Alcon$731
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$7,20042%
- Travel & lodging$1,1957%
- Food & beverage$8,78051%
- Education$400%
- Entertainment$1051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $8,794 |
| AbbVie(2 entities) | 93 | $1,781 |
| Sight Sciences, Inc. | 22 | $1,158 |
| Johnson & Johnson Surgical Vision, Inc. | 44 | $1,108 |
| Biotissue Holdings Inc. | 14 | $1,074 |
| Alcon | 21 | $731 |
| Bausch & Lomb Americas Inc. | 23 | $666 |
| Rxsight Inc | 4 | $513 |
| Mallinckrodt Hospital Products Inc. | 10 | $315 |
| Novartis | 9 | $156 |
| Optos, Inc. | 4 | $153 |
| Oyster Point Pharma, Inc. | 8 | $143 |
| Carl Zeiss Meditec USA, Inc. | 1 | $113 |
| Shire North American Group Inc | 8 | $110 |
| Amgen(2 entities) | 4 | $72 |
| Ivantis, Inc | 3 | $52 |
| Rayner Intraocular Lenses Limited | 3 | $51 |
| Genentech USA, Inc. | 2 | $47 |
| Glaukos Corporation | 3 | $46 |
| Sun Pharmaceutical Industries Inc. | 2 | $41 |
| Kala Pharmaceuticals, Inc. | 3 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Harrow Eye, LLC | 1 | $22 |
| Tarsus Pharmaceuticals, Inc. | 1 | $20 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Eyepoint US, Inc. | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Omeros Corporation | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOTEMAX SM$6,538
- PROLENSA$1,900
- RXSIGHT INJECTOR HANDPIECE$423
- RXSIGHT CONTACT LENS$423
- RXSIGHT INJECTOR CARTRIDGE$423
- LIGHT ADJUSTABLE LENS (LAL)$423
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$423
- Clareon$299
- OMNI(R) SURGICAL SYSTEM (US)$278
- DURYSTA$223
- PANORAMIC OPHTHALMOSCOPE$211
- OCT OPHTHALMOSCOPE$211
- Tecnis IOL$118
- IOLMaster 700$113
- NFC-700$105
How this compares
$17,321 in reported general payments places this provider in the 95th percentile of 125 ophthalmology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 43 | $54,133 |
| Prednisolone Acetate | 826 | $36,000 |
| XiidraLifitegrast | 20 | $14,448 |
| LumiganBimatoprost | 18 | $4,481 |
| CombiganBrimonidine Tartrate/Timolol | 18 | $3,973 |
| Latanoprost | 254 | $2,497 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 120 | $2,317 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 18 | $1,897 |
| Loteprednol Etabonate | 11 | $1,428 |
| ValacyclovirValacyclovir Hcl | 18 | $949 |
| Ketorolac Tromethamine | 36 | $565 |
| Dorzolamide Hcl | 19 | $367 |
| Acyclovir | 27 | $357 |
| Brimonidine Tartrate | 41 | $265 |
| Timolol Maleate | 15 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $1,781 | $62,58779 claims |
| Bausch & Lomb Americas Inc.Xiidra | $666 | $14,44820 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $8,794 | $1,42811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 125 ophthalmology providers in Arkansas.
Other ophthalmology in Jonesboro
- Thomas StankJonesboro$16K
- Joshua LittleJonesboro$4K
- Daniel SinesRogers$81K
- Mike McFarlandPine Bluff$63K
- Jennifer DoyleLittle Rock$38K
- James LinderMarion$18K
- Andrew PerinNorth Little Rock$4K
- Jeffrey HoltHot Springs$4K
- Jonathan CascianoLittle Rock$4K
- Christian HesterLittle Rock$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.